Immunochemical classes of myelomatosis. Including data from a therapeutic trial conducted by a Medical Research Council working party.
D000328:Adult; D000368:Aged; D000686:Amyloidosis / Q000150:complications; D000740:Anemia / Q000150:complications; D001536:Bence Jones Protein; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000150:complications; D007120:Immunochemistry; D007075:Immunoglobulin M; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000145:classification / Q000150:complications / Q000188:drug therapy / Q000276:immunology* / Q000401:mortality; D014511:Uremia / Q000150:complications; D005719:gamma-Globulins / Q000145:classification
D007075:Immunoglobulin M; D005719:gamma-Globulins; D003520:Cyclophosphamide; D001536:Bence Jones Protein; D008558:Melphalan